{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:07:44Z","timestamp":1784185664636,"version":"3.55.0"},"reference-count":60,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>This article describes the assessment of the lipophilicity of 18 new pseudothiohydantoin (2-aminothiazol-4(5H)-one) derivatives using experimental and computational methods. Previous studies have shown that the tested derivatives are inhibitors of 11\u03b2-hydroxysteroid dehydrogenase type 1 and inhibit the metabolic activity of selected cancer cell lines. Lipophilicity, as log kw and RM0, was determined using reversed-phase high-performance liquid chromatography (RP-HPLC) and reversed-phase thin-layer chromatography (RP-TLC), respectively. In both chromatographic methods, methanol served as a modifier of the mobile phase. The obtained RM0 values were higher than the log kw for most of the compounds analyzed. The chromatographically determined lipophilicity parameters were compared with those obtained using the commonly used VCCLAB software: milogP, AlogPs, AClogP, XLOGP2, and XLOGP3. Among the analyzed calculation methods, the best agreement with experimentally determined lipophilicity (both log kw and RM0) was demonstrated by milogP and AClogP values. All tested derivatives satisfied the Lipinski, Veber, Ghose, and Egan rules, indicating their favorable properties after oral administration. Additionally, in silico calculations of ADMET parameters revealed that most of the 18 compounds tested exhibited promising pharmacokinetic and toxicological properties, making them attractive drug candidates.<\/jats:p>","DOI":"10.3390\/ijms27146310","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:49:36Z","timestamp":1784184576000},"page":"6310","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integral Lipophilicity Studies with in Silico ADMET Parameter Analysis of Novel Pseudothiohydantoin Derivatives"],"prefix":"10.3390","volume":"27","author":[{"given":"Szymon","family":"Baumgart","sequence":"first","affiliation":[{"name":"Department of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copenicus University in Toru\u0144, 2 Jurasza Str., 85-089 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Redka","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copenicus University in Toru\u0144, 2 Jurasza Str., 85-089 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4137-2981","authenticated-orcid":false,"given":"Artur","family":"S\u0142omka","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, National Medical Institute of the Ministry of Interior and Administration, 137 Wo\u0142oska Str., 02-507 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5853-4214","authenticated-orcid":false,"given":"Renata","family":"Studzi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copenicus University in Toru\u0144, 2 Jurasza Str., 85-089 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The Global Epidemic of the Metabolic Syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.bmcl.2007.01.081","article-title":"Synthesis and activity of quinolinyl-methylene-thiazolinones as potent and selective cyclin-dependent kinase 1 inhibitors","volume":"17","author":"Chen","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"26241","DOI":"10.1039\/D1RA05277B","article-title":"Design, synthesis and mechanistic study of new benzenesulfonamide derivatives as anticancer and antimicrobial agents via carbonic anhydrase IX inhibition","volume":"11","author":"Nemr","year":"2021","journal-title":"RSC Adv."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00044-012-0098-7","article-title":"Synthesis, characterization, and biological evaluation of certain 1,3-thiazolone derivatives bearing pyrazoline moiety as potential anti-breast cancer agents","volume":"22","author":"Khalil","year":"2013","journal-title":"Med. Chem. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1248\/cpb.c20-00714","article-title":"Design and Synthesis of New CDK2 Inhibitors Containing Thiazolone and Thiazolthione Scafold with Apoptotic Activity","volume":"69","author":"Badawy","year":"2021","journal-title":"Chem. Pharm. Bull."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1021\/jm4014746","article-title":"Medicinal Chemistry of Inhibitors of 11\u03b2-Hydroxysteroid Dehydrogenase Type 1 (11\u03b2-HSD1)","volume":"57","author":"Scott","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e164599","DOI":"10.1172\/JCI164599","article-title":"Tumors produce glucocorticoids by metabolite recycling, not synthesis, and activate Tregs to promote growth","volume":"133","author":"Taves","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3109\/00498254.2013.769074","article-title":"Intestinal and hepatic first-pass extraction of the 11\u03b2-HSD1 inhibitor AMG 221 in rats with chronic vascular catheters","volume":"44","author":"Gao","year":"2014","journal-title":"Xenobiotica"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kupczyk, D., Studzi\u0144ska, R., Ko\u0142odziejska, R., Baumgart, S., Modrzejewska, M., and Wo\u017aniak, A. (2022). 11\u03b2-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases. J. Clin. Med., 11.","DOI":"10.3390\/jcm11206190"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.chroma.2017.09.015","article-title":"Thin layer chromatography in drug discovery process","volume":"1520","author":"Ciura","year":"2017","journal-title":"J. Chromatogr. A"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s11095-010-0303-7","article-title":"Lipophilicity and its relationship with passive drug permeation","volume":"28","author":"Liu","year":"2011","journal-title":"Pharm. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"12156","DOI":"10.1021\/acs.jmedchem.9b01813","article-title":"Integrating the Impact of Lipophilicity on Potency and Pharmacokinetic Parameters Enables the Use of Diverse Chemical Space during Small Molecule Drug Optimization","volume":"63","author":"Miller","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/17460441.2012.714363","article-title":"The influence of lipophilicity in drug discovery and design","volume":"7","author":"Arnott","year":"2012","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0731-7085(95)01504-E","article-title":"The effect of lipophilicity on the protein binding and blood cell uptake of some acidic drugs","volume":"13","year":"1995","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"124574","DOI":"10.1016\/j.jchromb.2025.124574","article-title":"Liquid chromatography in determination of pharmacokinetic properties of compounds in drug discovery process","volume":"1257","author":"Jakanovski","year":"2025","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00232-015-9778-9","article-title":"Permeability of the Blood-Brain Barrier: Molecular Mechanism of Transport of Drugs and Physiologically Important Compounds","volume":"248","author":"Fong","year":"2015","journal-title":"J. Membr. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1016\/j.bmcl.2008.07.071","article-title":"Physiochemical drug properties associated with in vivo toxicological outcomes","volume":"18","author":"Hughes","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.4155\/fmc-2018-0435","article-title":"Lipophilicity in drug design: An overview of lipophilicity descriptors in 3D-QSAR studies","volume":"11","author":"Ginex","year":"2019","journal-title":"Future Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modeling towards prediction paradaise?","volume":"2","author":"Waterbeemd","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1017\/S0033583515000190","article-title":"In silico ADME\/T modelling for rational drug design","volume":"48","author":"Wang","year":"2015","journal-title":"Q. Rev. Biophys."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Redka, M., Baumgart, S., Kupczyk, D., Kosmalski, T., and Studzi\u0144ska, R. (2023). Lipophilic Studies and In Silico ADME Profiling of Biologically Active 2-Aminothiazol-4(5H)-one Derivatives. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241512230"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J. Comb. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"120301","DOI":"10.1016\/j.lfs.2022.120301","article-title":"Overview of nanoparticulate strategies for solubility enhancement of poorly soluble drugs","volume":"291","author":"Khan","year":"2022","journal-title":"Life Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/minf.201000118","article-title":"In Silico Prediction of Caco-2 Cell Permeability by a Classification QSAR Approach","volume":"30","author":"Bermejo","year":"2011","journal-title":"Mol. Inform."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ta, G.H., Jhang, C.S., Weng, C.F., and Leong, M.K. (2021). Development of a Hierarchical Support Vector Regression-Based In Silico Model for Caco-2 Permeability. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13020174"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0006-291X(91)91647-U","article-title":"Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells","volume":"175","author":"Artursson","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1124\/dmd.122.000966","article-title":"Quantitative Prediction of Intestinal Absorption of Drugs from In Vitro Study: Utilization of Differentiated Intestinal Epithelial Cells Derived from Intestinal Stem Cells at Crypts","volume":"51","author":"Maeda","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Wu, Y.W., Ta, G.H., Lung, Y.C., Weng, C.F., and Leong, M.K. (2022). In Silico Prediction of Skin Permeability Using a Two-QSAR Approach. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14050961"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1021\/acs.jcim.6b00044","article-title":"In Silico Prediction of Volume of Distribution in Humans. Extensive Data Set and the Exploration of Linear and Nonlinear Methods Coupled with Molecular Interaction Fields Descriptors","volume":"56","author":"Lombardo","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Klimoszek, D., Jele\u0144, M., Do\u0142owy, M., and Morak-M\u0142odawska, B. (2024). Study of the Lipophilicity and ADMET Parameters of New Anticancer Diquinothiazines with Pharmacophore Substituents. Pharmaceuticals, 17.","DOI":"10.3390\/ph17060725"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1021\/acs.molpharmaceut.8b00785","article-title":"Predicting Fraction Unbound in Human Plasma from Chemical Structure: Improved Accuracy in the Low Value Ranges","volume":"15","author":"Watanabe","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1021\/acsomega.0c05846","article-title":"In Silico Prediction of Fraction Unbound in Human Plasma from Chemical Fingerprint Using Automated Machine Learning","volume":"6","author":"Mulpuru","year":"2021","journal-title":"ACS Omega"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1038\/s41596-018-0066-x","article-title":"Blood-brain-barrier organoids for investigating the permeability of CNS therapeutics","volume":"13","author":"Bergmann","year":"2018","journal-title":"Nat. Protoc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bpj.2014.06.024","article-title":"A method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulations","volume":"107","author":"Carpenter","year":"2014","journal-title":"Biophys. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1208\/s12248-021-00616-7","article-title":"Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: A Full-Spectrum Characterization","volume":"23","author":"Doohan","year":"2021","journal-title":"AAPS J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/jcph.2452","article-title":"Prediction of Pediatric Pharmacokinetics for CYP3A4 Metabolized Drugs: Comparison of the Performance of Two Hepatic Ontogeny Within a Physiologically Based Pharmacokinetic Model","volume":"64","author":"Codaccioni","year":"2024","journal-title":"J. Clin. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3389\/fphar.2020.00683","article-title":"In Silico Pharmacogenetics CYP2D6 Study Focused on the Pharmacovigilance of Herbal Antidepressants","volume":"11","author":"Don","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1742-7843.2005.pto_973160.x","article-title":"Assessment of CYP1A2 activity in clinical practice: Why, how, and when?","volume":"97","author":"Faber","year":"2005","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"20321","DOI":"10.1021\/acsomega.2c02315","article-title":"Assessment of the CYP1A2 inhibition-mediated drug interaction potential for pinocembrin using in silico, in vitro, and in vivo approaches","volume":"7","author":"Bhatt","year":"2022","journal-title":"ACS Omega"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/03602532.2020.1758714","article-title":"Inhibition of CYP2C9 by natural products: Insight into the potential risk of herb-drug interactions","volume":"52","author":"Wang","year":"2020","journal-title":"Drug Metab. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00228-017-2404-2","article-title":"In vitro studies and in silico predictions of fluconazole and CYP2C9 genetic polymorphism impact on siponimod metabolism and pharmacokinetics","volume":"74","author":"Jin","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"619","DOI":"10.31083\/ph.2018.8689","article-title":"CYP2C19 polymorphism in relation to the pharmacotherapy optimization of commonly used drugs","volume":"73","year":"2018","journal-title":"Pharmazie"},{"key":"ref_48","unstructured":"Horde, G.W., and Gupta, V. (2025). Drug Clearance. 2023 June 20. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1021\/ci1000295","article-title":"Predicting total clearance in humans from chemical structure","volume":"50","author":"Yu","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.toxrep.2024.04.001","article-title":"Maximum tolerated dose and toxicity evaluation of orally administered docetaxel granule in mice","volume":"12","author":"Dong","year":"2024","journal-title":"Toxicol. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13321-016-0117-7","article-title":"ADMET evaluation in drug discovery: 15. Accurate prediction of rat oral acute toxicity using relevance vector machine and consensus modeling","volume":"8","author":"Lei","year":"2016","journal-title":"J. Cheminform."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1021\/ci8001974","article-title":"Modeling oral rat chronic toxicity","volume":"48","author":"Mazzatorta","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"ref_53","unstructured":"(2024, August 24). pkCSM\u2014Pharmacokinetics. Available online: https:\/\/biosig.unimelb.edu.au\/pkcsm\/prediction."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/mutage\/gead033","article-title":"Ames test study designs for nitrosamine mutagenicity testing: Qualitative and quantitative analysis of key assay parameters","volume":"39","author":"Thomas","year":"2024","journal-title":"Mutagenesis"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Baumgart, S., Kupczyk, D., Archa\u0142a, A., Kosz\u0142a, O., So\u0142ek, P., P\u0142azi\u0144ski, W., P\u0142azi\u0144ska, A., and Studzi\u0144ska, R. (2023). Synthesis of Novel 2-(Cyclopentylamino)thiazol-4(5H)-one Derivatives with Potential Anticancer, Antioxidant, and 11\u03b2-HSD Inhibitory Activities. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087252"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Baumgart, S., Kupczyk, D., P\u0142azi\u0144ska, A., Kosz\u0142a, O., So\u0142ek, P., Archa\u0142a, A., P\u0142azi\u0144ski, W., and Studzi\u0144ska, R. (2025). New Derivatives of 2-(Cyclohexylamino)thiazol-4(5H)-one as Strong Inhibitors of 11\u03b2-Hydroxysteroid Dehydrogenase Type 1: Synthesis, Antiproliferative and Redox-Modulating Activity. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26188972"},{"key":"ref_57","first-page":"1617","article-title":"Chromatographic and Calculation Methods for Analysis of the Lipophilicity of Newly Synthesized Thiosemicarbazides and their Cyclic Analogues 1,2,4-Triazol-3-thiones","volume":"26","author":"Niejedli","year":"2015","journal-title":"J. Braz. Chem. Soc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/chromsci\/bmx054","article-title":"Chromatographic and Computational Assessment of Lipophilicity of New Anticancer Acetylenequinoline Derivatives","volume":"55","author":"Marciniec","year":"2017","journal-title":"J. Chromatogr. Sci."},{"key":"ref_59","unstructured":"(2025, March 06). Virtual Computational Chemistry Laboratory. Available online: http:\/\/vcclab.org\/lab\/alogps."},{"key":"ref_60","unstructured":"(2024, July 13). SwissADME. Available online: http:\/\/swissadme.ch."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6310\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:00:15Z","timestamp":1784185215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":60,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27146310"],"URL":"https:\/\/doi.org\/10.3390\/ijms27146310","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]}}}